$1.94
-0.08 (-3.96%)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
CAPS Rating:
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
RSS Headlines
Fool UK